390
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Increasing Incidence and Prevalence of Acquired Hemolytic Anemias in Denmark, 1980–2016

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 497-508 | Published online: 22 May 2020

References

  • Bottiger LE, Westerholm B. Acquired haemolytic anaemia. I. Incidence and aetiology. Acta Med Scand. 1973;193(3):223–226. doi:10.1111/j.0954-6820.1973.tb10567.x4739592
  • Klein NP, Ray P, Carpenter D, et al. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine. 2010;28(4):1062–1068. doi:10.1016/j.vaccine.2009.10.11519896453
  • Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun. 2007;29(1):1–9. doi:10.1016/j.jaut.2007.05.00217582741
  • Berentsen S, Ulvestad E, Langholm R, et al. Primary chronic cold agglutinin disease: a population based clinical study of 86 patients. Haematologica. 2006;91(4):460–466.16585012
  • Hill A, Platts PJ, Smith A, et al. The incidence and prevalence of paroxysmal nocturnal hemoglobinuria (PNH) and survival of patients in Yorkshire. Blood. 2006;108(11):985. doi:10.1182/blood.V108.11.985.985
  • Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev. 2010;24(4–5):143–150. doi:10.1016/j.blre.2010.06.00420650555
  • Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003;2(3):119–125. doi:10.1016/S1568-9972(03)00006-512848952
  • Dacie SJ. The immune haemolytic anaemias: a century of exciting progress in understanding. Br J Haematol. 2001;114(4):770–785. doi:10.1046/j.1365-2141.2001.02945.x11564063
  • Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol. 2002;69(4):258–271. doi:10.1002/ajh.1006211921020
  • Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84(3):223–243. doi:10.1006/clin.1997.44129281381
  • Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-324965263
  • Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S9112526604824
  • Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–591. doi:10.2147/CLEP.S17908331372058
  • Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. doi:10.1371/journal.pmed.100188526440803
  • Hansen DL, Overgaard UM, Pedersen L, Frederiksen H. Positive predictive value of diagnosis coding for hemolytic anemias in the Danish National Patient Register. Clin Epidemiol. 2016;8:241–252. doi:10.2147/CLEP.S9364327445504
  • Hansen DL, Moller S, Andersen K, Gaist D, Frederiksen H. Evans syndrome in adults - incidence, prevalence, and survival in a nationwide cohort. Am J Hematol. 2019;94(10):1081–1090. doi:10.1002/ajh.2557431292991
  • Mannering N, Hansen DL, Frederiksen H. Evans syndrome in children below 13 years of age – a nationwide population-based cohort study. PLoS One. 2020;15(4):e0231284. doi:10.1371/journal.pone.023128432271826
  • Stata Statistical Software: release 15 [computer program]. College Station, TX: StataCorp LLC; 2017.
  • Skov T, Deddens J, Petersen MR, Endahl L. Prevalence proportion ratios: estimation and hypothesis testing. Int J Epidemiol. 1998;27(1):91–95. doi:10.1093/ije/27.1.919563700
  • StataCorp. Stata Base Referecen Manual Release 15. Stata Press; 2017.
  • Statistics Denmark. Statbank; 2018 Available from: https://www.statbank.dk/. Accessed 519, 2019.
  • Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347(12):911–920. doi:10.1056/NEJMra02010012239261
  • Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007;26(9):1217–1225. doi:10.1111/j.1365-2036.2007.03502.x17944736
  • Norgard BM, Nielsen J, Fonager K, Kjeldsen J, Jacobsen BA, Qvist N. The incidence of ulcerative colitis (1995–2011) and Crohn’s disease (1995–2012) - based on nationwide Danish registry data. J Crohns Colitis. 2014;8(10):1274–1280. doi:10.1016/j.crohns.2014.03.00624675473
  • Laustrup H, Voss A, Green A, Junker P. Occurrence of systemic lupus erythematosus in a Danish community: an 8-year prospective study. Scand J Rheumatol. 2009;38(2):128–132. doi:10.1080/0300974080241907319117248
  • Pedersen JK, Svendsen AJ, Horslev-Petersen K. Incidence of Rheumatoid Arthritis in the Southern part of Denmark from 1995 to 2001. Open Rheumatol J. 2007;1:18–23. doi:10.2174/187431290070101001819088896
  • Andersson TM, Engholm G, Pukkala E, et al. Avoidable cancers in the Nordic countries-The impact of alcohol consumption. Eur J Cancer. 2018;103:299–307. doi:10.1016/j.ejca.2018.03.02729739641
  • Ocias LF, Larsen TS, Vestergaard H, Friis LS, Abildgaard N, Frederiksen H. Trends in hematological cancer in the elderly in Denmark, 1980–2012. Acta Oncol (Madr). 2016;55(sup1):98–107. doi:10.3109/0284186X.2015.1115124
  • Bylsma LC, Gulbech Ording A, Rosenthal A, et al. Occurrence, thromboembolic risk, and mortality in Danish patients with cold agglutinin disease. Blood Adv. 2019;3(20):2980–2985. doi:10.1182/bloodadvances.201900047631648316
  • Hadnagy C. Agewise distribution of idiopathic cold agglutinin disease. Z Gerontol. 1993;26(3):199–201.8337916
  • Luzzatto L, Risitano AM. Advances in understanding the pathogenesis of acquired aplastic anaemia. Br J Haematol. 2018;182(6):758–776. doi:10.1111/bjh.1544329974931
  • Gulbis B, Eleftheriou A, Angastiniotis M, et al. Epidemiology of rare anaemias in Europe. Adv Exp Med Biol. 2010;686:375–396.20824457
  • Gupta R, Pandey P, Choudhry R, et al. A prospective comparison of four techniques for diagnosis of paroxysmal nocturnal hemoglobinuria. Int J Lab Hematol. 2007;29(2):119–126. doi:10.1111/j.1751-553X.2006.00838.x17474884
  • Lima M. Laboratory studies for paroxysmal nocturnal hemoglobinuria, with emphasis on flow cytometry. Pract Lab Med. 2020;20:e00158. doi:10.1016/j.plabm.2020.e0015832195308
  • Hillmen P, Hall C, Marsh JC, et al. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2004;350(6):552–559. doi:10.1056/NEJMoa03168814762182
  • Anderson IB, Sorensen TI, Prener A. Increase in incidence of disease due to diagnostic drift: primary liver cancer in Denmark, 1943–85. BMJ (Clinical Research Ed). 1991;302(6774):437–440. doi:10.1136/bmj.302.6774.437
  • Arndt PA. Drug-induced immune hemolytic anemia: the last 30 years of changes. Immunohematology. 2014;30(2):44–54.25247622
  • Bass GF, Tuscano ET, Tuscano JM. Diagnosis and classification of autoimmune hemolytic anemia. Autoimmun Rev. 2014;13(4–5):560–564. doi:10.1016/j.autrev.2013.11.01024418298
  • Hill QA, Hill A, Berentsen S. Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment. Blood Adv. 2019;3(12):1897–1906. doi:10.1182/bloodadvances.201900003631235526
  • Jager U, Barcellini W, Broome CM. et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting. Blood Rev. 2019: 100648. doi:10.1016/j.blre.2019.10064831839434
  • Hill A, Hill QA. Autoimmune hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2018;2018(1):382–389. doi:10.1182/asheducation-2018.1.38230504336